Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1812 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Chemtura Enters Into Sourcing Agreement With Albemarle

Under the agreement, Chemtura will source BA-59PTM, DE-83RTM, Firemaster 2100, n-propyl bromide and sodium bromide from Albemarle. Additionally, Albemarle is assigning its brine interests in Chemtura’s West Brine

Celgene Acquires Gloucester

Celgene has acquired Gloucester for $340m in cash plus up to an additional $300m payable upon achievement of certain future regulatory milestones. The transaction brings to Celgene Istodax

BioCryst Completes Patient Enrollment In CTCL Study

Currently, over 143 patients are enrolled in the CTCL study. The study is a multinational, non-randomised, open-label, single-arm trial, evaluating 200mg once-daily oral Forodesine treatment. Reportedly, the study